Factors influencing depression endpoints research (FINDER): Study design and population characteristics
A Garcia-Cebrian(Eli Lilly (United Kingdom)), André Tylee(King's College London), Deborah Quail(Eli Lilly (United Kingdom)), Koen Demyttenaere(University Psychiatric Hospital), Michael Bauer(University Hospital Carl Gustav Carus), David Pérahia(École Normale Supérieure Paris-Saclay), Ángel L. Montejo(Universidad de Salamanca), Luigi Grassi(University of Ferrara), N. Dantchev, Paul Gandhi(Eli Lilly (United Kingdom)), Brigitta U. Monz(Boehringer Ingelheim (Germany))
Cited by 30
Related Papers
Genome-wide association study identifies 30 loci associated with bipolar disorder
|Nature Genetics|2019|1.6k
Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology
|Nature Genetics|2021|1.6k
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data
|Brain Imaging and Behavior|2014|884
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754